Industry

DUBLIN–(BUSINESS WIRE)–The “Global Interactive Patient Care (IPC) & Interactive Patient Engagement Solutions Market 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global interactive patient engagement solutions market is projected to reach USD 300 million by 2027 from USD 146 million in 2022, at a CAGR of 15.5% The growth of this market is driven … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Gynecological Cancer Drugs Market By Therapeutic Modality, By Indication: Global Opportunity Analysis and Industry Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering. The key factors that drive the market growth include, the high incidence of gynecological cancers, growth in the importance of targeted drug therapies, an increase in investment from government, public, … [Read more…]

Hera Biotech is developing the world’s first non-surgical test for definitive diagnosis and staging of endometriosis. SAN ANTONIO–(BUSINESS WIRE)–San Antonio-based medical device start-up Hera Biotech has closed an oversubscribed $1.9 million seed financing round to support the company’s commercialization strategy for its category-defining non-surgical diagnostic test for endometriosis, MetriDx™. The funds will be used to … [Read more…]

Dr. Betty Diamond and colleagues receive the Global Team Science Award to study the body’s recovery from lupus in diverse patient populations MANHASSET, N.Y.–(BUSINESS WIRE)–Millions worldwide and an estimated 200,000 people in the United States have lupus, of whom 90 percent are women. In an effort to translate basic molecular research into better therapy for … [Read more…]

BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth, a global healthcare and specialty pharmacy solutions company, has placed in the top one third on the annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. “Making the Inc. 5000 list for the second year in a row with a 317% three-year revenue growth is a significant … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “3D Printed Drugs Market Research Report by Technology (Direct-Write, Fused Deposition Modelling, and Inkjet Printing), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global 3D Printed Drugs Market size was estimated at … [Read more…]

POC Advisor’s real-time monitoring detects sepsis 6 hours earlier and guides the right clinical decisions WALTHAM, Mass.–(BUSINESS WIRE)–Each year in the United States, sepsis accounts for 270,000 deaths and costs nearly $27 billion — making it one of the largest cost drivers for U.S. hospitals.1 To quickly identify and best care for patients with sepsis … [Read more…]

BERWYN, Pa.–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced that Jeffrey Gudin, MD, will present a poster at the World Congress of World Institute of Pain entitled, “Enkephalin as … [Read more…]

Tisch MS Research Center of New York identifies key protein that causes motor disability and motor neuron degeneration in sALS, paving the way for first-of-its-kind treatment target for the disease NEW YORK–(BUSINESS WIRE)–The Larry G. Gluck Division of ALS Research, located at the Tisch MS Research Center of New York, has published research in Brain … [Read more…]

BETHESDA, Md.–(BUSINESS WIRE)–ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory indications, today announced the appointment of Peter Greenleaf to its board of directors. Mr. Greenleaf, a seasoned industry executive with nearly 30 years of experience leading successful life sciences companies, is currently the president, chief executive officer and member … [Read more…]